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Abstract
Introduction
In this study, we applied fluorescence in vivo hybridization (FIVH) using locked nucleic acid
(LNA) probes targeting the bacterial rRNA gene for in vivo detection of H. pylori infecting the
C57BL/6 mouse model. A previously designed Cy3_HP_LNA/2OMe_PS probe, complemen-
tary to a sequence of theH. pylori 16S rRNA gene, was used. First, the potential cytotoxicity
and genotoxicity of the probe was assessed by commercial assays. Further, the performance
of the probe for detectingH. pylori at different pH conditions was tested in vitro, using fluores-
cence in situ hybridization (FISH). Finally, the efficiency of FIVH to detectH. pylori SS1 strain
in C57BL/6 infected mice was evaluated ex vivo in mucus samples, in cryosections and paraf-
fin-embedded sections by epifluorescence and confocal microscopy.
Results
H. pylori SS1 strain infecting C57BL/6 mice was successfully detected by the Cy3_HP_LNA/
2OMe_PS probe in the mucus, attached to gastric epithelial cells and colonizing the gastric
pits. The specificity of the probe forH. pyloriwas confirmed bymicroscopy.
Conclusions
In the future this methodology can be used in combination with a confocal laser endomicro-
scope for in vivo diagnosis of H. pylori infection using fluorescent LNA probes, which would
be helpful to obtain an immediate diagnosis. Our results proved for the first time that FIVH
method is applicable inside the body of a higher-order animal.
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Introduction
Helicobacter pylori (H. pylori) colonizes the human gastric epithelium, representing the most
common infection worldwide [1]. This infection increases the risk for peptic ulcer disease, dis-
tal gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma [1,2]. Due to its
important role in gastric cancer development, H. pylori was recognised as a carcinogen (class
1) by the World Health Organization [3]. Therefore, a rapid, accurate and early diagnosis ofH.
pylori infection is crucial not only for individual patient management but also to identify indi-
viduals at high risk of developing gastric cancer. Currently, a number of diagnostic methods
are available to detect H. pylori [4]. Upper endoscopy allows the collection of gastric biopsy
specimens used to identify H. pylori by histology, culture, rapid urease tests, and PCR-based
methods [3]. Therefore, and with the exception of rapid urease tests, the diagnostic result is not
immediately obtained after endoscopy, requiring time and an experienced laboratory.
Confocal laser endomicroscopy (CLE) allows in vivo visualization and analysis of epithelial
mucosa using 1000x magnification [5]. Some studies have suggested that CLE images of
colonic mucosa have the potential to substitute conventional histological diagnostics [5,6,7].
However, only unspecific stains, such as fluorescein sodium and acriflavine have been used for
in vivo histology of the mucosal layer [8,9,10]. For this reason, only indirect evidence of the
presence of H. pylori infection can be observed [11]. Consequently, a precise and specific iden-
tification of this bacterium is not yet possible using this method.
Fluorescence in vivo hybridization (FIVH) can be applied in detecting DNA or RNA sequences
in living eukaryotic cells [12]. Nevertheless, to the best of our knowledge this method was never
employed to detect microorganisms directly in the human body, possibly due to the peptidoglycan
cell wall of the microorganisms that hinders the entry of the probes into the cell. Nucleic acid mim-
ics such as peptide nucleic acid (PNA), locked nucleic acid (LNA) and 2’-O-methyl-RNA (2OMe)
have been studied as diagnostic probes of infectious diseases and are capable of replacing conven-
tional DNA or RNA probes [13]. The key advantages of these mimics are the higher stability in
vivo [14,15,16] and the more favorable diffusion and hybridization properties than the correspond-
ing unmodified DNA or RNA probes [17,18]. However, the unsolved question of how these types
of probes can be used to detect clinically relevant bacteria remains. The different approaches that
have been undertaken to develop in vivo diagnostic methods mostly rely on the use of non-specific
stains or label oligonucleotides with radioactive isotopes such as halogens [19,20,21].
We recently reported the development of a LNA probe (HP_LNA/2OMe_PS) that specifi-
cally detects H. pylori in biopsies of infected patients, and in experimental conditions of
extreme acid pH and at 37°C [22,23]. Still, the performance of this probe for H. pylori in vivo
detection remained unknown.
Here, we provide the first FIVH protocol applied to an experimental mouse model ofH. pylori
infection, that successfully enables the detection of both free-swimming bacteria in the protective
mucus layer that overlays the stomach surface and bacteria colonizing gastric epithelial cells.
Materials and Methods
Oligonucleotide synthesis
The sequence of the probe was selected and synthesized based on the parameters described in
our previous studies [22,23] (Table 1).
Cell proliferation assay
The human gastric epithelial cell line AGS (ATCC1 CRL-1739) was cultured in RPMI medium
1640 Glutamax I (Gibco, Invitrogen, Grand Island, NY, USA) supplemented with 10% (v/v)
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fetal bovine serum (FBS, HyClone, Thermo Fisher Scientific, Inc, UK) and 1% (v/v) Penicillin/
Streptomycin (Gibco) at 37°C in a humidified 5% CO2 atmosphere. Cells were seeded at 1.6 x
105 cells/well in a 96-well plate. After overnight, media were changed and cells were incubated
with predetermined concentrations (0.4 μM to 2 μM) of Cy3_HP_ LNA/2OMe _PS probe
diluted in vehicle (0.5 M urea and 900 mMNaCl) or only with the vehicle, for 24 h. Cell viabil-
ity was assessed by CellTilter 961 Aqueous One Solution Cell Proliferation Assay (Promega
Corporation, Madison, WI), according to the manufacturer’s instructions. Untreated cells
served as a negative control. The experiments were performed in triplicate.
VITOTOX1Assay
To analyze if the Cy3_HyP_LNA/2’OMe probe can induce genotoxicity, the VITOTOX1
model from Gentaur (Aachen, Germany) was used. Briefly, this assay makes use of two recom-
binant Salmonella typhymurium reporter strains, the TA104 recN2-4 (Genox strain) and
TA104 pr1 (Cytox strain). The Cytox strain expresses bacterial luciferase from Vibrio fischeri,
encoded episomal. A reduction in the signal/noise of the luminescent signal indicates cytotox-
icity and an increase indicates interferences of the compound with the luminescent signal itself.
The Genox strain carries an integrated lux operon from Vibrio fischeri under transcriptional
control of the recN promoter. When a compound is genotoxic, transcription of the DNA repair
mechanism will lead to an increase of the luminescent signal. Addition of rat liver S9 fraction is
used to mimic the mammalian metabolic conditions so that the mutagenic potential of metab-
olites formed by a parent compound in the hepatic system can be assessed [24,25,26]. The
luminescence is measured for 4 h with a 5 min interval period in a plate-reading GloMax1
Discover System GM3000 luminometer (Promega, Madison, USA) and generally, when the
signal to noise ratio in the cytox strain model is reduced below 0.8, the compound is regarded
as cytotoxic for S. typhymurium and the genotoxicity cannot be studied. When the signal to
noise ratio in the genox strain model is above 1.5, the DNA repair mechanism is activated by
the cell as an early response to genotoxicity by the compound. The concentrations of Cy3
HP_LNA/2OMe_PS probe tested in this assay were of 0.04, 0.08, 0.2, 0.4, 1 and 2 μM. The
compound 4-nitroquinoline-oxide (4-NQO) (a direct acting base-altering mutagen) and benzo
[α]pyrene (BaP) (indirect mutagen which requires metabolic activation by S9 mix), were used
as positive controls. The experiments were performed in triplicate.
Bacteria and growth conditions
The mouse-adaptedHelicobacter pylori Sydney strain 1 (SS1), originally described by Lee et al., [27],
was kindly provided by Sara Lindén (Gothenburg University, Sweden).H. pylori SS1 was routinely
cultured for 48 h on Tryptic Soy Agar (TSA) plates (LabM Limited, Lancashire, UK) medium, sup-
plemented with 5% sheep blood (Oxoid, Cambridge, UK) at 37°C under micro-aerophilic condi-
tions (5%O2, 10% CO2, 85%N2), generated byWhitley H35 Hypoxystation (DonWhitley, West
Yorkshire, UK). For liquid cultures, bacteria were resuspended in Tryptic Soy Broth (TSB) (LabM
Limited, Lancashire, UK) containing 10% of fetal calf serum (FCS) (Invitrogen, Ghent, Belgium)
and grown overnight at 37°C, with shaking under microaerophilic conditions.
Table 1. Designation and sequence of probe containing locked nucleic acid (LNA; with L superscript)
and 2’-O-methyl-RNA (2’-OMe; in boldface) nucleotide monomers. Cy3_HP_LNA/2OMe_PS is a phos-
phorothioate oligomer (PS backbones), Cy3 (Cyanine).
Designation Sequence (10-mer)
Cy3 HP_ LNA/2OMe _PS 5'- Cy3 GLACTLAAGLCCCL-3’
doi:10.1371/journal.pone.0148353.t001
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Fluorescence in situ hybridization on slides
To determine if the probe Cy3-labeled HP_LNA/2OMe_PS detect the H. pylori SS1 strain, a
theoretical evaluation was performed against the 16 S rRNA from this bacterial strain, using
BLAST software (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Then, the hybridization of the Cy3
HP_LNA/2OMe_PS againstH. pylori SS1 was studied using LNA-FISH protocol on glass slides
as previously described by Fontenete et al., (2015), with few modifications. Briefly, 20 μL of H.
pylori SS1 liquid cultures were spread onto glass slides and the smears were allowed to air dry.
The hybridization was performed using 20 μL of hybridization buffer with 0.2 μM of the probe,
which covered each smear individually. Three different hybridization buffers were tested at dif-
ferent pH (2, 4, and 7), containing 0.5 M urea (BHD Prolabo, Haasrode, Belgium), 900 mM
NaCl (Panreac, Illinois, USA) and different buffer solutions to keep the desired pH (pH 2: KCl-
HCl, pH 4: phosphate-citrate, pH 7: Tris-HCl buffer). Smears were covered with coverslips and
incubated for 30 min at 37°C. Slides were subsequently washed in a gastric simulated juice that
contains pepsin for 15 min at 37°C and then, the slides were allowed to air dry. All experiments
were performed in triplicate and for each experiment a negative control (without a probe) was
included. For image acquisition a Carl Zeiss inverted Axiovert fluorescence microscope (Carl
Zeiss, Jena, Germany) was used. Cy3-labeling was excited by using a 565 nm laser; the exposure
time was fixed for all preparations.
Animals
Female specific-pathogen-free (SPF) from the inbred C57BL/6 (C57BL/6JRj strain) mice
(n = 24) were purchased from Janvier LABS (Le Genest-St-Isle, France). Animals were housed
in 332 × 150 × 130 cm (3 mice) or 382 × 220 × 150 cm (6 mice) autoclaved Micro-Isolater clear
plastic cages, with a ventilation rate of 10 to 15 air changes per hour (ACH), at 20°C, 50%
humidity and under a light/dark cycle of 12/12 h, with free access to standard rodent food
pellets (Carfil Quality, Turnhout, Belgium) and water. Cages were lined with B 8/20 chips for
bedding material, and with cardboard tubes and shredded paper as nesting material for envi-
ronmental enrichment. Animals were handled by trained and experienced personnel for rou-
tine maintenance and experimental procedures to reduce stress. To minimize variation in the
gut microflora, all animals within an experimental cohort were bred in the same room and
housed on the same rack in a specific pathogen-free barrier facility. All animal experimentation
was performed according to institutional guidelines and with approval of the local institute
review board, in accordance to the European Directive 2010/63/EU regulations.
Infection of mice with H. pylori SS1
Female SPF C57BL/6 mice were randomly allocated to 6 groups of 3 to 6 animals (Fig 1A).
Mice were inoculated intragastrically with two doses of 0.1 mL TSB containing 1x109 H. pylori
CFU/mL by oral gavage (with polyethylene catheters attached to 1 mL disposable syringes, Bio-
trol, Paris, France). The administration was performed at two time points, with an interval of 1
hour, in two consecutive days. In the control groups, mice were given TSB alone. Mice were
fasted from 4 h before infection until 4 h after oral gavage. Mice were sacrificed by cervical dis-
location, 2 weeks post-infection for collection of stomach and detection of H. pylori by FIVH.
FlVH procedure and assessment in mice
FIVH procedure was performed 15 days post-infection (Fig 1A). Cy3-labeled HyP_LNA/
2’OMe probe, diluted in an adjuvant buffer contained 0.5 M urea and 900 mMNaCl), was
given by oral gavage at 0.5 μM (group I and group V) or 2 μM concentration (group II and
Fluorescence In Vivo Hybridization (FIVH)
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group VI) (Fig 1B). After 30 min, animals were sacrificed by cervical dislocation (Fig 1A). The
stomach of each animal was removed in aseptic conditions and opened along the greater
curvature.
The stomach contents were removed and samples of the mucus were recovered in cover-
slips. After that, the glandular stomachs were washed in physiological buffered saline and
divided into tissue fragments representing cardia, body and antrum. Half of the stomach was
used for H. pylori culture. The remaining half of the glandular stomach was equally divided in
two parts. One part was rinsed in PBS with 0.01%NaN3 and immediately frozen in liquid nitro-
gen in Optimal Cutting Temperature compound (OCT; Sakura FInetek, USA) for
Fig 1. FIVH scheme used for detectingH. pylori in C57BL/6 mice. A. Four control groups with n = 3 (group I to IV) were used to evaluate the background
of the vehicle (group I) and tissue (group II) and the specificity of the Cy3_HyP_LNA/2’OMe probe (groups III and IV). Two tests groups (n = 6, each group)
were used with different probe concentrations, 0.5 μM (group V) and 2 μM (group VII). B. Animal study protocol depicting H. pylori inoculation, time of
infection in C57BL/6 mice, and FIVH after 15 days post-infection.
doi:10.1371/journal.pone.0148353.g001
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histopathological examination and analysis of fluorescence. Tissue cryosections (10 μm) were
prepared. The other part of the stomach was fixed in 4% paraformaldehyde (PAF, Sigma-
Aldrich), for 1 hour, at room temperature. Afterwards, the tissue was rinsed 3 times for PBS
and stored in PBS with 0.01% NaN3 at 4°C, before being processed and embedded in paraffin.
Tissue sections with 3 μmwere obtained.
The detection of FIVH signal was performed ex vivo in mucus samples, paraffin-embedded
sections and cryosections. Mucus and cryosections were evaluated using a Carl Zeiss inverted
Axiovert fluorescence microscope. Paraffin-embedded sections were evaluated using a Nikon
Eclipse Ti-E inverted microscope attached to a microlens-enhanced dual spinning disk confo-
cal system (UltraVIEW VoX; PerkinElmer, Seer Green, UK) equipped with 405, 488 and 561
nm diode lasers for excitation of blue, green and red fluorophores, respectively. Images were
acquired and processed using Volocity image analysis software (Improvision, PerkinElmer,
Waltham, USA).
Retention of Cy3 HP_LNA/2OMe_PS probe in the mouse stomach
To evaluate the retention of the probe in the gastric mucosa, an extra experiment was per-
formed using a group of mice with a period of 5 days post-infection. The infection procedure
was performed as described in section 8. Each mouse in the group was administered 2 μM of
Cy3_HyP_LNA/2’OMe probe through oral gavage. Mice were killed after 24 h and the stomach
were processed and analyzed as previously described.
Evaluation of H. pylori colonization in infected mice
The presence ofH. pylori infection was determined by viable bacterial counts (CFU, colony
forming units) and histopathological evaluation. To quantify bacteria on stomachs samples, as
a measure of the colonization level, tissues fragments were mechanically homogenized in 1 mL
TSB (TissueRuptor, QIAgen). The homogenates were serially diluted and then plated in dupli-
cate onto TSA plates, supplemented with 5% sheep blood, vancomycin (10 μg/mL), trimethro-
prim (5 μg/mL), amphotericin (5 μg/mL) and cefsulodin (10 μg/mL) (all purchased from
Sigma-Aldrich) and incubated at 37°C under microaerophilic conditions. After 5 days of incu-
bation, H. pylori colonies were identified and enumerated as CFU per gram of stomach.
Statistical analysis
Statistical significance was determined by One-way analysis of variance (ANOVA) using
GraphPad PRISM 5 software (GraphPad Software, San Diego, USA). Results were expressed as
mean ± SD. Differences were considered to be statistically significant when p< 0.05.
Results
HyP_LNA/2’OMe probe in vitro toxicity study
To address if the Cy3-labelled HP_LNA/2OMe_PS probe affects gastric cell viability, we incu-
bated a gastric epithelial cell line, AGS, with different concentrations of the probe and evalu-
ated cell viability using the MTS assay. The range of concentrations of the Cy3_HyP_LNA/
2’OMe probe tested on AGS cells, between 0.4 μM and 2 μM did not affect cell viability, since
no statistically significant differences were found for any of the concentrations tested
(p> 0.05) relatively to the untreated cells (Fig 2).
Fluorescence In Vivo Hybridization (FIVH)
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Evaluation of genotoxicity of the HyP_LNA/2’OMe probe by
VITOTOX1Assay
For detecting a possible DNA damage (genotoxicicty) caused by the HyP_LNA/2’OMe probe,
the VITOTOX1 assay was used. This assay allows to study the presence of genotoxicity by
measuring the activation of the SOS DNA-repair system induced by genotoxic compounds
[24,25]. A Genox/Cytox ratio higher than 1.5 indicates the presence of a genotoxic compound.
Two positive controls 4-NQO (positive control without S9 activation) and B(α)P (positive con-
trol with S9 activation) were used in this assay [25,26]. The results from the VITOTOX1
assay are shown in Fig 3. A serial dilution of the probe was tested ranging from 0.04 μM to
2 μM. The tested concentrations of the probe did not reduce the signal to noise ratio of the
treated cytox cultures below 0.8 (C in Fig 3). This was also the case after addition of the S9 liver
extract in the TA104 pr1 strain, indicating lack of toxicity towards the S. typhymuriummodel
and enabling to test for genotoxicity. The signal to noise ratio of the luminescence emitted by
the genox strain did not exceeded 1.5 before and after addition of the S9 liver extract (G in Fig
3). At the tested concentrations, the activation of the SOS DNA repair mechanism and early
signs of genotoxicity elicited by the Cy3_HyP_LNA/2’OMe probe or its possible metabolites
could not be observed.
Fluorescence in situ hybridization (FISH) of Cy3_HP_LNA/2OMe_PS
probe on H. pylori SS1 smears
To evaluate whether the Cy3_HP_LNA/2OMe_PS probe is able to detect H. pylori SS1 we per-
formed FISH in smears, at different pH values of the hybridization solutions. As it can be
observed in Fig 4, a high fluorescent signal was detected in H. pylori SS1 smears at all condi-
tions tested. This is similar to what we have reported before for smears of other strains ofH.
pylori [22] with, in which high fluorescence was obtained at pH 4 using a non-fixative protocol.
Fig 2. Effect of the Cy3_HP_LNA/2OMe_PS probe on viability of AGS gastric epithelial cells using the
MTS assay. AGS cells were treated with a range of concentrations of the Cy3_HP_LNA/2OMe_PS probe for
24 h (0.4 μM to 2 μM). Results are expressed as the mean ± SEM of three independent experiments,
performed in triplicate; No statistical significant differences were found regarding probe-treated vs untreated
control cells (p>0.05 by ANOVA).
doi:10.1371/journal.pone.0148353.g002
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Bacteria colonization of the gastric mucosa in C57BL/6 mice
Before the detection of H. pylori SS1-infecting C57BL/6 mice by FIVH, we assessed the effi-
ciency of colonization in the experimental animal groups to assure that any difference in FIVH
signal was not attributed to differences in the colonization levels of bacteria. For that, we quan-
tified the bacterial burden in the stomach of each infected mice by counting the CFU per gram
of stomach tissue (Fig 5). At 2 weeks of infection, all mice had an established infection. No dif-
ferences in bacterial burden were found in the stomachs of infected animals, since CFU levels
were equivalent regardless of delivery or not of probe and vehicle. Further, no H. pylori were
found in the non-infected control animals.
Assessment of H. pylori in the mice stomach by FIVH
Having demonstrated that H. pylori SS1 colonization of C57BL/6 mice was similar in all animal
groups tested (Fig 5), we assessed the efficiency of FIVH experiments by microscopical obser-
vation of both mucus samples (surface mucus layer) and mucosa sections from each mouse. At
2-weeks post-infection, it was possible to observe free-swimming H. pylori within the surface
of the mice mucus (Fig 6), as well as attached to gastric epithelial cells (Figs 7 and 8), the major
locations of H. pylori infection in the stomach [28], as identified by the fluorescent signal of the
probe. Both concentrations of the Cy3_HP_LNA/2OMe_PS probe studied 0.5 μM (Fig 6A and
6B) and 2 μM (Fig 6D and 6E) were effective in FIVH for the mucus samples of test groups V
and VI. Surface mucus samples collected from infected control groups without probe (groups I
and II) and from uninfected control groups (groups III and IV) showed no detectable fluores-
cence emission in the red channel (S1 Fig).
Fig 3. VITOTOX1 assay for detection of signs of genotoxicity caused by the Cy3_HyP_LNA/2’OMe probe. Results are expressed as the signal-to-
noise (S/N) ratio between exposed and unexposed VITOTOX1 test bacteria (Genox or Cytox strain) in the absence or presence of S9 mix. Bap:benzo[α]
pyrene, the positive control, only turns genotoxic after S9 metabolisation.
doi:10.1371/journal.pone.0148353.g003
Fluorescence In Vivo Hybridization (FIVH)
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Next, for the detection ofH. pylori SS1 in the gastric mucosa of mice, we used both cryosec-
tions and paraffin-embedded sections of the mice stomach. It has been described that, although
physically less stable, cryosections are generally superior for the preservation of the fluores-
cence signals and therefore for detection by microscopy [29]. As it can be observed in Figs 7
and 8, the detection of H. pylori SS1 infection, using FIVH with the Cy3-labeled HP_LNA/
2OMe_PS probe, was successful in both frozen and paraffin-embedded stomach sections of the
infected test groups V (0.5 μM probe) and VI (2 μM probe).
Although the Cy3_HP_LNA/2OMe _PS probe was effective at detecting bacteria at both
concentrations tested, the bacterial morphology was better defined when higher concentration
of the probe was used in the case of paraffin-embedded sections (Fig 8C and 8D). In paraffin-
embedded sections it was possible to detect free-swimming bacteria in the mucus layer nearby
the surface of epithelial cells, as well asH. pylori adhered to the surface mucus cells (Fig 8A–
8C). Furthermore, it was possible to visualize H. pylori colonizing the glands (Fig 8B and 8D).
A low background in the red channel was observed in infected controls groups (group I and
II) in cryosections (S2A–S2D Fig), whereas no detectable red fluorescence emission was found
in paraffin-embedded sections (S3A and S3B Fig). No red fluorescent signal (non-specific sig-
nal) was observed in non-infected control groups where the Cy3-labeled probe was
Fig 4. Detection ofH. pylori SS1 in slides, by fluorescence in situ hybridization (FISH) using the Cy3_HP_LNA/2OMe_PS probe at different pH
values, analyzed by epifluorescencemicroscopy. A to C—FISH protocol performed on smears of pure cultures of H. pylori SS1 incubated with 0.2 μM of
probe. D to F—FISH protocol on smears ofH. pylori SS1 cultures without probe used as negative control. A and D—Experiments performed at pH 2. B and E
—Experiments performed at pH 4. C and F—Experiments performed at pH 7. All images were taken at equal exposure times. Scale bar: 10 μm.
doi:10.1371/journal.pone.0148353.g004
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administrated without H. pylori (S2E–S2H Fig for cryosections, and S3C and S3D Fig for paraf-
fin-embedded section; group III and IV).
To analyze the retention time of the Cy3_HP_LNA/2OMe_PS probe in the gastric mucosa
after FIVH, we increased the period post-FIVH from 30 min to 24 h. The probe was adminis-
trated at a concentration of 2 μM to a group of 3mice at day 5 post-infection. After 24 h of the
FIVH, mice were sacrificed and the infection was confirmed by counting the bacterial CFUs
(S4 Fig), and the stomach of each mouse was analyzed using fluorescence signal (Fig 9). The
number of CFUs obtained from the stomach of mice with a 5 days-infection (S4 Fig) was lower
than that obtained from mice with a 15 days-infection. No signal was observed in the red chan-
nel in the surface of the mice mucus (Fig 9A), and few bacteria were observed in frozen sections
(Fig 9B). In contrast, in paraffin-embedded sections it was possible to detect H. pylori adhered
to gastric epithelial cells (Fig 9C), indicating that the probe was retained in the stomach, though
the fluorescence intensity was rather lower (Fig 9B and 9C).
Discussion
In the present study, we evaluated the efficiency of detection of H. pylori using in vivo labeling
with a Cy3_HP_LNA/2OMe_PS probe directed against the 16S rRNA sequence, by FIVH on a
mouse model. C57BL/6 mice were infected for 15 days withH. pylori SS1 strain and FIVH was
Fig 5. Viable bacterial counts (CFU, colony-forming units) from stomachs of mice infected withH. pylori SS1 strain for 2 weeks. Scatter plot of CFU
for each animal, with bars representing the mean value.
doi:10.1371/journal.pone.0148353.g005
Fluorescence In Vivo Hybridization (FIVH)
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performed 30 min before mice were sacrificed. Our results demonstrated that H. pylori can be
successfully detected in the gastric mucosa of mice. Moreover, the Cy3_HP_LNA/2OMe_PS
probe showed high in vivo specificity with low background.
The detection of molecules in living cells constitutes an important field of study in biology
and medical diagnostics. Therefore, efforts have been carried out to develop specific methods to
target different molecules, such as proteins, mRNA, miRNA, and rRNA, mainly based on fluores-
cent probes [30,31,32,33]. Successful detection of fluorescent probes depend on several character-
istics, namely: high fluorescence level and specificity, high in vivo stability and high spatial
resolution [34]. The FIVH term was introduced byWiegant et al. in 2010, to described a method
to microinject a 2’OMe probe into live eukaryotic cells in culture [35]. Later on, other studies
have also used fluorescence labeled oligonucleotides to target or regulate molecules in vivo
[32,36,37,38]. This in vivo labeling methodology can be applied to address the challenge of a fast
diagnosis of microbial infections in humans. The aim is to use FIVH in the future, for real-time
detection ofH. pylori during upper endoscopy using confocal laser endomicroscopy (CLE) [5].
LNA probes have been applied in vivomainly for therapeutic purposes [39,40]. To the best
of our knowledge, there are no in vivo studies that use LNA probes for diagnostic purposes.
Previously, we reported that the Cy3_HP_LNA/2OMe_PS probe was non-toxic at the con-
centration of 0.2 μM against the gastric AGS cell line [22]. In the present study, higher
Fig 6. Detection ofH. pylori SS1 in the surface of gastric mucus frommice subjected to FIVH with
0.5 μM (A and B; group V) and 2 μM (C and D; group VI) of the Cy3_HP_LNA/2OMe_PS probe. Samples
were collected and visualized directly using the epifluorescence microscope. Arrows indicate free-swimming
H. pylori in the surface of mice gastric mucus. All images were taken at equal exposure times and are
representative of the respective test group. Channels red, green and DAPI are overlapped. Scale bars:
10 μm.
doi:10.1371/journal.pone.0148353.g006
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concentrations of the probe were needed for in vivo experiments. Therefore, viability analysis
using a range of concentration between 0.4 μM and 2 μM of the Cy3_ HP_ LNA/2OMe _PS
probe was performed in AGS cells. Although selected studies have demonstrated some toxicity
associated to LNA probes [41,42], no statistically significant changes in cell viability were
observed within the range of probe concentrations tested in this study. Further, the possibility
of genotoxic effects induced by the Cy3_HP_LNA/2OMe_PS probe was also investigated.
According to the results, the probe was not genotoxic, even at high concentrations. To our
knowledge this is the first report that tests the genotoxicity of LNA probes. Since the VITO-
TOX1 test is known to correlate very well with the Ames assay, which is essentially a gene
mutation assay [43], we can conclude that the Cy3_HP_LNA/2OMe_PS probe does not induce
genotoxicity by aSOS-induction mechanism.
Additionally, the detection of H. pylori SS1 strain by the Cy3_HP_LNA/2OMe_PS probe
was confirmed by FISH on smears of pure cultures of this bacterium, using a range of pH con-
ditions, as well as with a simplified protocol without permeabilization. Although this step is
crucial for FISH in bacterial suspensions as we previously reported [22], it is dispensable when
using bacteria smears. This simplification of the protocol is relevant for in vivo experiments,
since it will reduce animal manipulations, time and toxicity of the reagents used.
Fig 7. Detection ofH. pylori SS1 in frozen sections of gastric mucosa frommice subjected to FIVH, 30
min before euthanasia. A and B: mice from group V (0.5 μM of the Cy3_HP_LNA/2OMe_PS probe), C and
D: group VI (2 μM of the Cy3_HP_LNA/2OMe _PS probe). Arrows indicate the presence of H. pylori infecting
the gastric mucosa. All images were taken at equal exposure times, with overlapping of the red, green and
DAPI channels. All the images from each group are representative of n = 6 mice. A and C- scale bars: 50 μm.
B and D- scale bars: 10 μm.
doi:10.1371/journal.pone.0148353.g007
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Regarding the in vivo detection of H. pylori, our results have shown that the Cy3_HP_
LNA/2OMe_PS probe was effective in detecting H. pylori-infected mice at both probe concen-
trations tested (0.5 μM and 2 μM), and in different locations (within the mucus and attached to
gastric epithelial cells). Although we were able to detect H. pylori in the surface of the mucus
samples collected from infected mice, we did not observe a high concentration of bacteria at
this location (Fig 6). Contrastingly, a high density ofH. pylori was found in the mucus layer
nearby the stomach surface (e.g. Fig 8A and Fig 8C) or attached to the surface of epithelial cells
(e.g. Fig 8B). This is in agreement with already published reports [28,44,45,46]. For instance,
Schreiber et al., described that H. pylori colonizes the mucus layer located 0–25 μm above the
Fig 8. Detection ofH. pylori SS1 in paraffin sections of gastric mucosa frommice test groups subjected to FIVH with the Cy3_HP_LNA/2OMe_PS
probe 30min before being sacrificed. A and C. Fluorescence images of the detection in the surface of the gastric mucosa. B and D. Fluorescence images
of the detection in the epithelium. A-B images obtained frommouse stomachs from group V. C-D images obtained frommouse stomachs from group VI. Red,
green and DAPI channels are overlapped. All the images from each group are representative of n = 6 mice. A, B and C scale bars: 10 μm; D scale bars:
50 μm.
doi:10.1371/journal.pone.0148353.g008
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tissue surface and that the remaining part of the mucus layer was almost free of bacteria [28].
In fact, one cannot expect a substantial amount ofH. pylori cells to be present in the surface of
the mucus, where the pH is low and proximate to the lumen pH, thus an adverse niche for the
maintenance and replication of H. pylori.
We can also conclude that the Cy3_HP_LNA/2OMe_PS probe, administered by oral
gavage, had a good retention 24 hrs post-FIVH (Fig 9C) in the mice stomach lining and was
able to diffuse into deeper regions of the mice gastric epithelium (Fig 8), since it detectedH.
pylori in the inner mucus layer and at the entrance of gastric pits. It is accepted that the pres-
ence ofH. pylori closer to the epithelial surface probably facilitates exchanges between the
adherent and swimming populations of bacteria [28,47].
Importantly, and as mentioned above, the Cy3_HP_LNA/2OMe_PS probe is able to detect
microorganisms in the close vicinity of the gastric epithelium, without being affected by
extreme conditions of the stomach, as we suggested in our previous study [22]. Thus, the mice
stomach environment was not an obstacle for the detection ofH. pylori using our probe,
administered by oral gavage, and the FIVH conditions tested here. However, one of the vari-
ables that might affect the detection by FIVH is the amount of H. pylori that are infecting the
stomach. In this study, we have achieved standard levels of contamination by this bacterium
(Fig 5). The adaptability of this method for situations where a low level of infection exists was
not studied.
Improvements in the methodology still have to be addressed in the future in order to
include FIVH in the routine clinical practice. The use of CLE is at the moment limited to the
equipment available in the market that have an excitation wavelength of 488 nm, which is not
compatible with the Cy3 fluorochrome (wavelength around 530–560 nm). Thus, it will be nec-
essary to modify the fluorochrome of the probe. In our previous study [22], we showed that
fluorescein-labeled probes had low fluorescence when exposed to gastric fluid juice. Therefore,
our future work will comprise selection of a different label not only compatible with CLE
devices, but also that preserves characteristics such as high brightness, low photobleaching,
higher biostability, low toxicity, and a competitive price. Overall, and although there are still
some limitations that need to be addressed, the FIVH methodology described herein represents
a remarkable advance towards the in vivo diagnosis of H. pylori infection. Adding to the possi-
bility of detecting pathogens in vivo, FIVH will also allow to localize microorganisms directly
within the human body. At the moment, a large number of studies have associated gut
Fig 9. Retention of the Cy3_HP_LNA/2OMe_PS probe in the mouse stomach infected withH. pylori SS1 for 5 days, and subjected to a FIVH period
of 24 hrs before being sacrificed. A. Sample of gastric mucus. B. Frozen section of mouse gastric mucosa. C. Paraffin section of mouse gastric mucosa.
Detection of H. pylori SS1 by the Cy3-labeled probe is depicted by white arrows. A and B: Red, green and DAPI channels were overlapped. C. Red and DAPI
channels are overlapped. All the images from each group are representative of n = 3 mice. Scale bars: 10 μm.
doi:10.1371/journal.pone.0148353.g009
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microbiota with different diseases [48,49], but there are no available technologies to visualize
directly the microorganisms and asses their spatial interactions with other microorganisms and
with human tissues. The application of FIVH would hence allow to complement the knowledge
on the population structure with information about preferred locations of the microorganisms,
with a final goal of better understanding the physical-chemical interactions between all the
cells of the human complex ecosystem.
In summary, we have evaluated the in vivo diagnostic potential of a LNA based probe for
the detection of H. pylori by FIVH in an infected C57BL/6 mouse model. Overall, our results
showed that the Cy3-labeled HP_LNA/2OMe_PS probe using the developed FIVH protocol
allows the detection H. pylori, both within gastric mucus and attached to gastric epithelial cells.
This holds great promise towards an effective, safe, and immediate method for in vivo diagnosis
ofH. pylori infection in human patients, applying a confocal laser endomicroscope. Moreover,
this methodology can be applied to the study of the detection patterns of bacteria to different
anatomic sites that may be relevant during infection processes and for the identification and
localization of different components of the microbiome.
Supporting Information
S1 Fig. Analysis of the specificity of Cy3 HP_ LNA/2OMe _PS probe and the background
in vivo in samples of surface gastric mucus from mice control groups. Samples were col-
lected and analyzed directly under the epifluorescence microscope. A and B: group I, C and D:
group II, E and F: group III, G and H: group IV. All images were taken at equal exposure times.
Channel red, green and DAPI were overlapping. Scale bars: 10 μm.
(TIFF)
S2 Fig. Analysis of the specificity of Cy3 HP_ LNA/2OMe _PS probe and the background
in vivo in cryosections from gastric mucosa of control groups. A and B: group I, C and D:
group II, E and F: group III, G and H: group IV. All the images are representative of n = 3 mice.
All images were taken at equal exposure times. Channel red, green and DAPI were overlapping.
Scale bars: 10 μm.
(TIF)
S3 Fig. Analysis of specificity of Cy3 HP_ LNA/2OMe and background in paraffin sections
of mouse stomach from control groups. A-B: Background obtained using the vehicle and
water from group I and II, respectively. C—D. Distribution of Cy3 HP_ LNA/2OMe _PS probe
in mouse stomach of group III and IV, respectively. All the images are representative of n = 3
mice. All images were taken at equal exposure times. Channel red, green and DAPI were over-
lapping. Scale bars: 50 μm.
(TIF)
S4 Fig. Quantification of bacterial burden in the stomach ofH. pylori-infected mice with 5
days of post-infection. Bars represent medium values.
(TIF)
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